Literature DB >> 32508401

Chemiluminescent microparticle immunoassay-based detection and prevalence of Toxoplasma gondii infection in childbearing women (Iran).

Hossein Sobati1.   

Abstract

Toxoplasmosis is a common zoonotic disease, which is of particular importance in women before and during pregnancy. In this study, the chemiluminescent microparticle immunoassay was used to detect Toxoplasma gondii and the seroepidemiology of Toxoplasma gondii was investigated among childbearing women in Qom, Iran. In this study, 202 blood samples were collected from childbearing women for evaluation of toxoplasmosis. Serum samples were isolated to determine anti-Toxoplasma IgM and IgG antibodies. Based on findings, the total prevalence of anti-Toxoplasma antibodies was 134 (66.3%) [95% CI 59.6-72.5]. In addition, 133 (65.8%) [95% CI 59.1-72.1], 19 (9.4%) [95% CI 6.1-14.2] and 18 (8.9%) [95% CI 5.7-13.6] samples were IgG-positive, IgM-positive and positive for both antibodies, respectively. The highest infection rate was reported over the age of 35 years, and positive lgM antibodies were detected in women below 29 years. T. gondii infection showed a significant correlation with age, pregnancy, contact with cats, exposure to soil, and consumption of raw food (P < 0.05). The serological tests revealed that nearly 33.7% [95% CI 27.5-40.4] of women at childbearing age (49.1% [95% CI 36.4-61.9] of pregnant women versus 27.9% [95% CI 21.3-35.6] of non-pregnant women) had no anti-Toxoplasma antibodies. Therefore, this population is more prone to acute infections with Toxoplasma. © Indian Society for Parasitology 2020.

Entities:  

Keywords:  Childbearing age; Detection; IgG; IgM; Immunoassay; Seroepidemiology; Toxoplasma gondii

Year:  2020        PMID: 32508401      PMCID: PMC7244674          DOI: 10.1007/s12639-019-01190-8

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  28 in total

1.  In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis.

Authors:  Zohreh Mohammadi Azad; Hoda Moravej; Mahdi Fasihi-Ramandi; Faramarz Masjedian; Raziyeh Nazari; Reza Mirnejad; Mehrdad Moosazadeh Moghaddam
Journal:  J Med Microbiol       Date:  2017-07-12       Impact factor: 2.472

2.  Investigation of the antimicrobial activity of a short cationic peptide against promastigote and amastigote forms of Leishmania major (MHRO/IR/75/ER): An in vitro study.

Authors:  Sara Khalili; Elahe Ebrahimzade; Mehdi Mohebali; Parviz Shayan; Samira Mohammadi-Yeganeh; Mehrdad Moosazadeh Moghaddam; Samira Elikaee; Behnaz Akhoundi; Mohammad Kazem Sharifi-Yazdi
Journal:  Exp Parasitol       Date:  2018-11-26       Impact factor: 2.011

Review 3.  An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection.

Authors:  S Fallahi; A Rostami; M Nourollahpour Shiadeh; H Behniafar; S Paktinat
Journal:  J Gynecol Obstet Hum Reprod       Date:  2017-12-08

4.  Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays.

Authors:  Eva Sickinger; Françoise Gay-Andrieu; Gesa Jonas; Jan Schultess; Myriam Stieler; Darwin Smith; Michael Hausmann; René Stricker; Reto Stricker; Jens Dhein; Hans-Bertram Braun
Journal:  Diagn Microbiol Infect Dis       Date:  2008-08-20       Impact factor: 2.803

5.  Evaluation of the Abbott ARCHITECT Toxo IgM assay.

Authors:  Eva Sickinger; Hans-Bertram Braun; Gerald Praast; Myriam Stieler; Cordelia Gundlach; Claudia Birkenbach; John Prostko; Mary Ann Palafox; Edwin Frias; Stephen Hsu; Matthew Matias; Dominick Pucci; Michael Hausmann; Ulrich Sagel; Darwin Smith
Journal:  Diagn Microbiol Infect Dis       Date:  2009-05-22       Impact factor: 2.803

6.  Prevalence of and risk factors for malaria, filariasis, and intestinal parasites as single infections or co-infections in different settlements of Gabon, Central Africa.

Authors:  Noé Patrick M'bondoukwé; Eric Kendjo; Denise Patricia Mawili-Mboumba; Jeanne Vanessa Koumba Lengongo; Christelle Offouga Mbouoronde; Dieudonné Nkoghe; Fousseyni Touré; Marielle Karine Bouyou-Akotet
Journal:  Infect Dis Poverty       Date:  2018-01-30       Impact factor: 4.520

7.  Toxoplasma gondii Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis.

Authors:  Ze-Dong Wang; Huan-Huan Liu; Zhan-Xi Ma; Hong-Yu Ma; Zhong-Yu Li; Zhi-Bin Yang; Xing-Quan Zhu; Bin Xu; Feng Wei; Quan Liu
Journal:  Front Microbiol       Date:  2017-03-09       Impact factor: 5.640

8.  Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Miguel Francisco Mercado-Suarez; Alfredo Rodríguez-Briones; Laura Fallad-Torres; Julio Octavio Ayala-Ayala; Luis Jorge Nevarez-Piedra; Ehecatl Duran-Morales; Sergio Estrada-Martínez; Oliver Liesenfeld; José Angel Márquez-Conde; Sergio Arturo Martínez-García
Journal:  BMC Infect Dis       Date:  2007-07-13       Impact factor: 3.090

9.  Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study.

Authors:  Hendrik Wilking; Michael Thamm; Klaus Stark; Toni Aebischer; Frank Seeber
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

Review 10.  Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food.

Authors:  Karen Shapiro; Lillian Bahia-Oliveira; Brent Dixon; Aurélien Dumètre; Luz A de Wit; Elizabeth VanWormer; Isabelle Villena
Journal:  Food Waterborne Parasitol       Date:  2019-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.